Literature DB >> 27400667

Prostate cancer: Why the prostate arm of the PLCO trial failed and what it has taught us.

Matthew R Cooperberg1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27400667     DOI： 10.1038/nrurol.2016.116

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-07-17       Impact factor: 25.391

2.  Reevaluating PSA Testing Rates in the PLCO Trial.

Authors:  Jonathan E Shoag; Sameer Mittal; Jim C Hu
Journal:  N Engl J Med       Date:  2016-05-05       Impact factor: 91.245

3.  Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Authors:  Paul F Pinsky; Amanda Blacka; Barnett S Kramer; Anthony Miller; Philip C Prorok; Christine Berg
Journal:  Clin Trials       Date:  2010-06-22       Impact factor: 2.486

4.  Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Claudine Isaacs; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Ann W Hsing; Grant Izmirlian; Paul F Pinsky; Barnett S Kramer; Anthony B Miller; John K Gohagan; Philip C Prorok
Journal:  J Natl Cancer Inst       Date:  2012-01-06       Impact factor: 13.506

5.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

6.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

7.  Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.

Authors:  Ahmedin Jemal; Stacey A Fedewa; Jiemin Ma; Rebecca Siegel; Chun Chieh Lin; Otis Brawley; Elizabeth M Ward
Journal:  JAMA       Date:  2015-11-17       Impact factor: 56.272

Review 8.  Screening for prostate cancer.

Authors:  Dragan Ilic; Molly M Neuberger; Mia Djulbegovic; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

9.  Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.

Authors:  Robert L Grubb; Paul F Pinsky; Robert T Greenlee; Grant Izmirlian; Anthony B Miller; Thomas P Hickey; Thomas L Riley; Jerome E Mabie; David L Levin; David Chia; Barnett S Kramer; Douglas J Reding; Timothy R Church; Lance A Yokochi; Paul A Kvale; Joel L Weissfeld; Donald A Urban; Saundra S Buys; Edward P Gelmann; Lawrence R Ragard; E David Crawford; Philip C Prorok; John K Gohagan; Christine D Berg; Gerald L Andriole
Journal:  BJU Int       Date:  2008-12       Impact factor: 5.588

10.  Recruitment in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: the first phase of recruitment at Henry Ford Health System.

Authors:  Lois E Lamerato; Pamela M Marcus; Gordon Jacobsen; Christine Cole Johnson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04       Impact factor: 4.254
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.